Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Total Liabilities (2020 - 2025)

Historic Total Liabilities for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $201.6 million.

  • GeneDx Holdings' Total Liabilities fell 131.89% to $201.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.6 million, marking a year-over-year decrease of 131.89%. This contributed to the annual value of $174.1 million for FY2024, which is 870.61% down from last year.
  • Latest data reveals that GeneDx Holdings reported Total Liabilities of $201.6 million as of Q3 2025, which was down 131.89% from $186.7 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Total Liabilities high stood at $407.6 million for Q2 2021, and its period low was $163.0 million during Q3 2023.
  • In the last 5 years, GeneDx Holdings' Total Liabilities had a median value of $195.1 million in 2024 and averaged $224.8 million.
  • Its Total Liabilities has fluctuated over the past 5 years, first skyrocketed by 126633.1% in 2021, then crashed by 5371.69% in 2022.
  • Quarter analysis of 5 years shows GeneDx Holdings' Total Liabilities stood at $166.0 million in 2021, then soared by 42.92% to $237.2 million in 2022, then decreased by 19.6% to $190.7 million in 2023, then decreased by 8.71% to $174.1 million in 2024, then grew by 15.8% to $201.6 million in 2025.
  • Its last three reported values are $201.6 million in Q3 2025, $186.7 million for Q2 2025, and $189.0 million during Q1 2025.